ClinPharmPod

ClinPharmPod is the clinical pharmacology podcast from the journal Clinical Pharmacology and Therapeutics. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics. |
DISCLAIMER: The Publisher, Society and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this podcast; the views and opinions expressed do not necessarily reflect those of the Publisher, Society and Editors.

Orphan Drugs
Published 11/28/16

This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October issue here.


Pharmacogenetics
Published 4/21/16


This episode features Aaron S. Kesselheim, MD, JD, MPH of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read the commentary here.


Microdosing Studies in Children: A US Regulatory Perspective
Published 9/15/2015


This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary "Microdosing Studies in Children: A US Regulatory Perspective" which published in the September issue. Read the commentary here.


Medical Education on Cannabis and Cannabinoids
Published 6/19/2015


This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here.


Mitochondrial Medicine
Published 12/16/14


In this episode, Geoff Marsh interviews Dr. Hazel Szeto, from the Department of Pharmacology at the Cornell University Medical College, about the evolving discipline of mitochondrial medicine.


Evidence for clinical utility of pharmacogenetic testing
Published 10/01/14


In this episode, Geoff Marsh interviews Dr. Federico Innocenti, from the UNC Institute for Pharmacogenomics and Individualized Therapy, and Dr. Julie Johnson, from the University of Florida College of Pharmacy, about the clinical utility of pharmacogenetic testing.


The utility of genotype-guided warfarin dosing
Published 6/24/14


In this episode, Geoff Marsh interviews Dr. Larisa Cavallari, Associate Professor and Director of the Center for Pharmacogenomics at the University of Florida, about her evaluation of recent trials into the benefits of genotype-guided warfarin dosing.


Clinical Pharmacogenetics Implementation Consortium (CPIC) gene/drug guidelines: background and plans for the future
Published 3/25/14


In this episode, Geoff Marsh interviews Dr. Relling on the background and future plans for the Clinical Pharmacogenetics Implementation Consortium (CPIC) gene/drug guidelines.


Solving the drug shortage problem
Published 1/23/13


In this podcast, Geoff Marsh interviews Dr. Woodcock of the FDA about the current shortages of generic sterile injectible drugs. Rewarding the quality of products could be the first step towards solving the problem.


Sex and Lifestyle Drugs
Published 12/20/10


Listen in on our two-part podcast on the challenges, complexities, and change for pressing issues in sexual health. Our first segment features Dr. Carl Spana discussing crucial issues surrounding the treatment of female sexual dysfunction followed by Dr. Timothy R. Apodaca addressing the reasons and sources behind adolescent abuse of ED medication.


Nutraceuticals
Published 1/28/10


Join presenter Chelsea Wald as she discusses nutraceuticals. Botanical and herbal supplements are gaining popularity - but do they work? And are they safe? Organized by Christine Haller.


Emerging Infections
Published 8/26/09


In this show, presenter Chelsea Wald tackles the topic of emerging infectious diseases. She hears about the challenges of developing vaccines for elusive viruses, and takes a look at how to treat patient groups who are most vulnerable to infection.